BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21726161)

  • 41. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of almotriptan in triptan-experienced and triptan-naïve patients.
    Pascual J; Diener HC
    Curr Med Res Opin; 2007 Oct; 23(10):2433-40. PubMed ID: 17723158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies.
    Silberstein SD; Armellino JJ; Hoffman HD; Battikha JP; Hamelsky SW; Stewart WF; Lipton RB
    Clin Ther; 1999 Mar; 21(3):475-91. PubMed ID: 10321417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Health outcomes evaluations: estimating the impact of almotriptan in managed care settings.
    Mayo KW; Osterhaus JT
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S85-93. PubMed ID: 11859909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Almotriptan in the treatment of migraine attacks in clinical practice: results of the TEA 2000 observational study].
    Pascual J; Láinez JM; Leira R; Titus F; Mateos V; Galván J;
    Neurologia; 2003; 18(1):7-17. PubMed ID: 12590376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
    Sandrini G; Dahlöf CG; Mathew N; Nappi G
    Int J Clin Pract; 2005 Nov; 59(11):1356-65. PubMed ID: 16236092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Update on menstrual migraine: from clinical aspects to therapeutical strategies.
    Allais G; Benedetto C
    Neurol Sci; 2004 Oct; 25 Suppl 3():S229-31. PubMed ID: 15549543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Menstrually associated migraine.
    De Matteis E; Ornello R; Sacco S
    Handb Clin Neurol; 2024; 199():331-351. PubMed ID: 38307655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A review of the use of frovatriptan in the treatment of menstrually related migraine.
    Allais G; Benedetto C
    Ther Adv Neurol Disord; 2013 Mar; 6(2):55-67. PubMed ID: 23483096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Almotriptan in the treatment of migraine.
    Sandrini G; Perrotta A; Arce Leal NL; Buscone S; Nappi G
    Neuropsychiatr Dis Treat; 2007 Dec; 3(6):799-809. PubMed ID: 19300615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [CME "Takotsubo cardiomyopathy].
    Weidmann P
    Praxis (Bern 1994); 2012 Jun; 101(13):817; author reply 817. PubMed ID: 22792554
    [No Abstract]   [Full Text] [Related]  

  • 53. Current and emerging pharmacotherapy for menstrual migraine: a narrative review.
    Ceriani CEJ; Silberstein SD
    Expert Opin Pharmacother; 2023 Apr; 24(5):617-627. PubMed ID: 36946205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allodynia in Menstrually Related Migraine: Score Assessment by Allodynia Symptom Checklist (ASC-12).
    Melhado EM; Thiers Rister HL; Galego DR; de Oliveira AB; Buttarello IA; Belucio IS; Oliveira Marcos JM; Xavier MLT; Peres MFP
    Headache; 2020 Jan; 60(1):162-170. PubMed ID: 31637701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postmeningitis headache: case report.
    Matta AP; Ribas MC; Moreira Filho PF
    Arq Neuropsiquiatr; 2007 Jun; 65(2B):521-3. PubMed ID: 17665028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Profile of the antimigraine drug almotriptan].
    Pascual J
    Neurologia; 2002 Feb; 17(2):101-8. PubMed ID: 11864558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?
    Tiranini L; Cucinella L; Martella S; Bosoni D; Martini E; Nappi RE
    Expert Rev Neurother; 2023 Apr; 23(4):377-388. PubMed ID: 37038655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Myocardial infarction in a patient free of coronary artery disease].
    Ekström K; Lönnberg A; Anttonen O
    Duodecim; 2016; 132(11):1069-73. PubMed ID: 27400593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Migraine and serotonin: the quest for the Holy Grail goes on.
    Schoenen J
    Cephalalgia; 2014 Mar; 34(3):163-4. PubMed ID: 24065716
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical aspects of perimenstrual headaches.
    Taylor FR
    Curr Pain Headache Rep; 2009 Feb; 13(1):75-81. PubMed ID: 19126376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.